Long-Term Cancer and Mortality After Thymectomy

Area of Science:

• Cardiothoracic Surgery
• Oncology
• Immunology

Background:

• Long-term health outcomes after adult thymectomy remain unclear.
• Previous studies suggested potential links to increased mortality, cancer, and autoimmune diseases.
• These associations may be influenced by patient selection and surgical indications.

Purpose of the Study:

• To investigate the long-term health effects of thymectomy in adults.
• To compare outcomes of thymectomy with matched cardiothoracic procedures up to 10 years post-surgery.
• To address concerns raised by prior studies on thymic excision outcomes.

Main Methods:

• Propensity score-matched retrospective cohort study.
• Comparison of patients undergoing thymectomy versus other cardiothoracic procedures (coronary artery bypass, valve surgery).
• Follow-up extended to 10 years, assessing all-cause mortality, new malignancy, and autoimmune disease.

Main Results:

• Thymectomy was not associated with increased all-cause mortality at 5 or 10 years (HR 0.78, 95% CI 0.54-1.13 at 10 years).
• No significant difference in extrathymic malignancy incidence (2.3% vs 1.8%) or immune-related disease was observed between groups.
• Higher mortality was noted in patients with thymic malignancy; insufficient data for Myasthenia Gravis (MG) patients.

Conclusions:

• Adult thymectomy does not appear to confer a generalized survival disadvantage.
• Outcomes are influenced by the indication for surgery, with thymic malignancy associated with increased mortality.
• Caution is advised for incidental thymic removal, while findings do not support a broad survival penalty for thymectomy.